
Molecule: SECUKINUMAB
ChEMBL ID: CHEMBL1743068
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2015

Molecule: IXEKIZUMAB
ChEMBL ID: CHEMBL1743034
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2016

Molecule: AFASEVIKUMAB
ChEMBL ID: CHEMBL2109469
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: PERAKIZUMAB
ChEMBL ID: CHEMBL2109470
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CJM-112
ChEMBL ID: CHEMBL4297926
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Unknown

Molecule: BIMEKIZUMAB
ChEMBL ID: CHEMBL4297700
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2021

Molecule: M-1095
ChEMBL ID: CHEMBL4298023
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: REMTOLUMAB
ChEMBL ID: CHEMBL4297863
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: IZOKIBEP
ChEMBL ID: CHEMBL4297686
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: TIBULIZUMAB
ChEMBL ID: CHEMBL3990000
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: VUNAKIZUMAB
ChEMBL ID: CHEMBL4298102
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
